# Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis

> **NCT07711262** · PHASE3 · RECRUITING · sponsor: **Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.** · enrollment: 550 (estimated)

## Conditions studied

- Seasonal Allergic Rhinitis

## Interventions

- **DRUG:** Rupatifen Fumarate Capsules
- **DRUG:** Rupatadine Fumarate Tablets
- **DRUG:** Rupatifen Fumarate Capsules Placebo
- **DRUG:** Rupatadine Fumarate Tablets Placebo

## Key facts

- **NCT ID:** NCT07711262
- **Lead sponsor:** Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-18
- **Primary completion:** 2027-10
- **Final completion:** 2027-12
- **Target enrollment:** 550 (ESTIMATED)
- **Last updated:** 2026-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07711262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07711262, "Rupatifen Fumarate Capsules in Patients With Seasonal Allergic Rhinitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07711262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*